Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma

Neoadjuvant chemoradiotherapy has been used for patients with locally advanced esophageal squamous cell carcinoma (ESCC). However, the optimal dose of radiation therapy and the effect of lymphadenectomy after neoadjuvant therapy on patient outcomes are uncertain. We retrospectively reviewed the data...

Descripción completa

Detalles Bibliográficos
Autores principales: Pai, Chu-Pin, Chien, Ling-I, Huang, Chien-Sheng, Hsu, Han-Shui, Hsu, Po-Kuei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457289/
https://www.ncbi.nlm.nih.gov/pubmed/36078989
http://dx.doi.org/10.3390/jcm11175059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457289/
https://www.ncbi.nlm.nih.gov/pubmed/36078989
http://dx.doi.org/10.3390/jcm11175059

Ejemplares similares